Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking
暂无分享,去创建一个
Weiliang Zhu | Weihua Li | Yun Tang | Jiagao Cheng | Weiliang Zhu | Hualiang Jiang | Weihua Li | Yun Tang | Hong Liu | Jiagao Cheng | Hong Liu | Hualiang Jiang
[1] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[2] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[3] Weihua Li,et al. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION , 2005, Drug Metabolism and Disposition.
[4] J. Goldstein,et al. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension , 2005, Pharmacogenetics and genomics.
[5] Weiliang Zhu,et al. Possible Pathway(s) of Metyrapone Egress from the Active Site of Cytochrome P450 3A4: A Molecular Dynamics Simulation , 2007, Drug Metabolism and Disposition.
[6] Jose Cosme,et al. Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.
[7] D. Zeldin. Epoxygenase Pathways of Arachidonic Acid Metabolism* , 2001, The Journal of Biological Chemistry.
[8] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[9] Xiang Fang,et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. , 2004, Progress in lipid research.
[10] K. Nagata,et al. In vitro inhibition of human small intestinal and liver microsomal astemizole O -demethylation: different contribution of CYP2J2 in the small intestine and liver , 2003, Xenobiotica; the fate of foreign compounds in biological systems.
[11] K. Lindpaintner,et al. Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 , 2004, Circulation.
[12] James R. Halpert,et al. An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] C David Stout,et al. Structure of Human Microsomal Cytochrome P450 2C8 , 2004, Journal of Biological Chemistry.
[14] H. Mohrenweiser,et al. Cloning of CYP2J2 gene and identification of functional polymorphisms. , 2002, Molecular pharmacology.
[15] Weihua Li,et al. Functional role of residues in the helix B' region of cytochrome P450 2B1. , 2005, Archives of biochemistry and biophysics.
[16] G. Blaschke,et al. Investigation of the stereoselective metabolism of the chiral H1-antihistaminic drug terfenadine by high-performance liquid chromatography. , 1995, Journal of chromatography. A.
[17] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[18] T. Poulos,et al. High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.
[19] R. Wade,et al. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms. , 2000, Journal of molecular biology.
[20] M. Sippl. Recognition of errors in three‐dimensional structures of proteins , 1993, Proteins.
[21] L. Waskell,et al. Theoretical study of the ligand–CYP2B4 complexes: Effect of structure on binding free energies and heme spin state , 2004, Proteins.
[22] S. Imaoka,et al. Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. , 2002, The Journal of pharmacology and experimental therapeutics.
[23] Eric F. Johnson,et al. Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-Å Resolution , 2004, Journal of Biological Chemistry.
[24] R. Wade,et al. Exceptionally stable salt bridges in cytochrome P450cam have functional roles. , 1997, Biochemistry.
[25] T. Matsubara,et al. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[26] Jose Cosme,et al. Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.
[27] D E McRee,et al. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.
[28] K. Tomer,et al. Molecular Cloning and Expression of CYP2J2, a Human Cytochrome P450 Arachidonic Acid Epoxygenase Highly Expressed in Heart (*) , 1996, The Journal of Biological Chemistry.
[29] L. Waskell,et al. Erratum: Theoretical study of the ligand-CYP2B4 complexes: Effect of structure on binding free energies and heme spin state (Protiens: Structure, Function and Bioinformatics (2004) 55 (895-914)) , 2004 .
[30] Gordon C K Roberts,et al. Residues Glutamate 216 and Aspartate 301 Are Key Determinants of Substrate Specificity and Product Regioselectivity in Cytochrome P450 2D6* , 2003, The Journal of Biological Chemistry.
[31] Slobodan Petar Rendic. Summary of information on human CYP enzymes: human P450 metabolism data , 2002, Drug metabolism reviews.
[32] J. Halpert,et al. Site-directed mutagenesis as a tool for molecular modeling of cytochrome P450 2B1. , 1995, Biochemistry.
[33] J. Halpert,et al. A Rational Approach to Re-engineer Cytochrome P450 2B1 Regioselectivity Based on the Crystal Structure of Cytochrome P450 2C5* , 2003, The Journal of Biological Chemistry.
[34] C David Stout,et al. Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. , 2003, Biochemistry.
[35] Y T Chang,et al. Homology modeling, molecular dynamics simulations, and analysis of CYP119, a P450 enzyme from extreme acidothermophilic archaeon Sulfolobus solfataricus. , 2000, Biochemistry.
[36] C David Stout,et al. Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦ , 2007, Journal of Biological Chemistry.
[37] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[38] J. Thompson,et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.
[39] D. Mansuy,et al. Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid. , 2003, Archives of biochemistry and biophysics.
[40] O. Gotoh,et al. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.
[41] Ilme Schlichting,et al. Structure and chemistry of cytochrome P450. , 2005, Chemical reviews.
[42] Kwang-Hyeon Liu,et al. Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity , 2005, Pharmacogenetics and genomics.
[43] Eric F. Johnson,et al. The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution* , 2004, Journal of Biological Chemistry.
[44] K. Tomer,et al. CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance. , 1996, Molecular pharmacology.
[45] J. Halpert,et al. Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity. , 2000, The Journal of pharmacology and experimental therapeutics.
[46] D. Zeldin,et al. Variability of CYP2J2 Expression in Human Fetal Tissues , 2006, Journal of Pharmacology and Experimental Therapeutics.
[47] D. Grant,et al. Distribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human Tissues , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[48] C David Stout,et al. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen , 2005, Nature Structural &Molecular Biology.
[49] D. Zeldin,et al. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. , 2005, Cancer research.
[50] Eric F. Johnson,et al. The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.
[51] J. Halpert,et al. Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles. , 2001, Molecular pharmacology.
[52] Frank E. Blaney,et al. Crystal Structure of Human Cytochrome P450 2D6* , 2005, Journal of Biological Chemistry.
[53] Kwang-Hyeon Liu,et al. Characterization of Ebastine, Hydroxyebastine, and Carebastine Metabolism by Human Liver Microsomes and Expressed Cytochrome P450 Enzymes: Major Roles for CYP2J2 and CYP3A , 2006, Drug Metabolism and Disposition.
[54] Wei Zhang,et al. A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..
[55] Chris de Graaf,et al. Cytochrome p450 in silico: an integrative modeling approach. , 2005, Journal of medicinal chemistry.
[56] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[57] T. Sjögren,et al. Structural basis for ligand promiscuity in cytochrome P450 3A4 , 2006, Proceedings of the National Academy of Sciences.